Taysha Gene Therapies, Inc. - Common Stock (NQ:TSHA)
Price and Volume
Detailed Quote| Volume | 825,710 |
| Open | 5.890 |
| Bid (Size) | 5.750 (1,500) |
| Ask (Size) | 5.760 (1,600) |
| Prev. Close | 5.860 |
| Today's Range | 5.630 - 5.960 |
| 52wk Range | 2.540 - 7.300 |
| Shares Outstanding | 64,465,037 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Earnings Scheduled For November 4, 2025 ↗
November 04, 2025
Taysha (TSHA) Q1 2026 Earnings Transcript ↗
May 07, 2026
Taysha (TSHA) Q4 2025 Earnings Call Transcript ↗
March 19, 2026
Why Is Taysha Gene Therapies Stock Falling Friday? ↗
October 17, 2025
Frequently Asked Questions
Is Taysha Gene Therapies, Inc. - Common Stock publicly traded?
Yes, Taysha Gene Therapies, Inc. - Common Stock is publicly traded.
What exchange does Taysha Gene Therapies, Inc. - Common Stock trade on?
Taysha Gene Therapies, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Taysha Gene Therapies, Inc. - Common Stock?
The ticker symbol for Taysha Gene Therapies, Inc. - Common Stock is TSHA on the Nasdaq Stock Market
What is the current price of Taysha Gene Therapies, Inc. - Common Stock?
The current price of Taysha Gene Therapies, Inc. - Common Stock is 5.755
When was Taysha Gene Therapies, Inc. - Common Stock last traded?
The last trade of Taysha Gene Therapies, Inc. - Common Stock was at 08/03/26 01:36 PM ET
What is the market capitalization of Taysha Gene Therapies, Inc. - Common Stock?
The market capitalization of Taysha Gene Therapies, Inc. - Common Stock is 371.00M
How many shares of Taysha Gene Therapies, Inc. - Common Stock are outstanding?
Taysha Gene Therapies, Inc. - Common Stock has 371M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube